China National Accord Medicines Corporation Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 36,128.91 million compared to CNY 33,163.09 million a year ago. Net income was CNY 674.22 million compared to CNY 741.45 million a year ago.

Basic earnings per share from continuing operations was CNY 1.2077 compared to CNY 1.3308 a year ago.